Nektar Therapeutics (NKTR), a clinical-stage, global biopharmaceutical company developing innovative therapies that selectively modulate the immune system to treat autoimmune diseases, has a clinical trial catalyst to watch this month.The anticipated milestone is the upcoming data readout of the lead drug candidate Rezpegaldesleukin in patients with atopic dermatitis.Rezpegaldesleukin, also known ...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.